The Concept Life Sciences Group expands its services to the US
The Concept Life Sciences Group, offers a range of services to clients in the pharmaceutical, biotech, agrochemical, petrochemical, chemical, food, environmental and consumer industries and has launched its services in the US
The group was created following the acquisition of Peakdale Molecular, Scientific Analysis Laboratories and Resource and Environmental Consultants and was further expanded following the acquisition of CXR Biosciences and Agenda1 Analytical Services in 2015.
The US team will be led by Heidi Schulze, business development director, North America, who will be driving the sales efforts on the East coast and coordinating with the West Coast business team, according to the group.
Concept Life Sciences Group said its combination of expertise is unique in the market and enables companies to access a broad range of services with one point of contact.
With companies across a number of sectors facing challenges to achieve and maintain profitable growth, outsourcing remains a significant opportunity, according to the group.
Michael Fort, chairman, Concept Life Sciences Group, said: “The way we have structured our business enables us to provide project support as efficiently as end-to-end support to our clients.
“We can work with specific functional areas or work alongside a client from first concept through to the clinic door. This approach has been of significant interest to customers within the UK but has also attracted the attention of customers in the US.
“We have tested our ability to offer our services here and, after a successful pilot, have now officially launched our US offering. ”
Concept Life Sciences said that over 70% of its team who work in the discovery and development division are PhD scientists experienced in complex chemistry, pharmacology and pathways analysis working alongside their biology colleagues, who are experts in investigative and mechanistic toxicology, exploratory and discovery toxicology, PK and metabolic and dermal absorption.
Additionally, through their analytics division, Concept Life Sciences said it offers over 35 different analytical techniques including specialist characterisation instrumentation, chromatography and formulation/salt/polymorph screening to complete the Design, Make, Test cycle.
Fort said: “The rationale for the creation of the Concept Life Sciences Group was the recognition that there is a need in the market for a services organisation that has a proven track record in discovery science, problem solving and collaboration.
“We have built an organisation that delivers one of the widest range of analytical services available in Europe and are now keen to offer those services further afield.”